- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- March 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- February 2025
- 185 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- July 2024
- 150 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- December 2022
- 110 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- January 2019
- 30 Pages
China
From €2100EUR$2,200USD£1,759GBP
- Report
- January 2024
- 143 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- January 2022
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Report
- August 2024
- 80 Pages
Japan
From €3340EUR$3,500USD£2,799GBP
- Report
- February 2024
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- December 2022
- 90 Pages
Europe
From €1432EUR$1,500USD£1,199GBP
- Report
- May 2022
- 59 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- July 2024
- 280 Pages
Global
From €2534EUR$2,655USD£2,123GBP

The Follicle Stimulating Hormone (FSH) market is a subset of the Sexual and Reproductive Health Drugs market. FSH is a hormone produced by the pituitary gland that stimulates the growth and maturation of ovarian follicles in women and spermatogenesis in men. It is used to treat infertility, delayed puberty, and hypogonadism. FSH is also used in assisted reproductive technologies such as in vitro fertilization (IVF).
FSH is available in both injectable and oral forms. The injectable form is the most commonly used and is available in both brand name and generic versions. The oral form is only available in brand name versions.
The FSH market is highly competitive, with many companies offering products in both the injectable and oral forms. Some of the major players in the market include Merck, Ferring Pharmaceuticals, Teva Pharmaceuticals, and Pfizer. Show Less Read more